The combination of classical renal function parameters with biomarker levels, e.g., kidney injury molecule-1, interleukin 6, midkine and neutrophil gelatinase-associated lipocalin (NGAL), has led to the introduction of the concept of biomarker-based subtypes of AKI [3–9]. The gene discussed is LCN2; the disease is acute kidney injury.